Open access peer-reviewed chapter

Staphylococcal Infection and Infertility

Written By

Liyun Shi, Huanhuan Wang and Zhe Lu

Submitted: October 5th, 2015 Reviewed: February 23rd, 2016 Published: June 29th, 2016

DOI: 10.5772/62663

Chapter metrics overview

4,374 Chapter Downloads

View Full Metrics


Staphylococcus sp. is not only a commensal bacterium but also a major human pathogen that causes a wide range of clinical infections, such as skin and soft tissue infection, pleuropulmonary and osteoarticular infection, and endocarditis as well as life-threatening systemic infections. More evidence is currently emerging to show that Staphylococcus, particularly Staphylococcus aureus, can colonize the reproductive systems and affect their structure and function. Staphylococcal infection has become one of the most common causes of infertility in both males and females. This chapter focuses on the epidemiology, pathophysiology, clinical manifestations, and treatment of staphylococcal infection and infertility.


  • Staphylococcus
  • infection
  • infertility

1. Introduction

Bacterial infection in reproductive organs is one of the most common causes of infertility in both male and female patients. It is also associated with sexually transmitted infections and adverse pregnancy outcomes. Infection with different microorganisms, such as chlamydia, mycoplasma, and certain bacteria, may lead to various clinical manifestations of human reproductive function. Staphylococcussp., although a commensal bacterium, is a leading cause of skin and soft tissue infections and life-threatening systemic infections. More evidence is currently emerging to support the vaginal colonization of Staphylococcussp. and its involvement in heterosexual transmission and infertility, but the knowledge is relatively scarce. In this chapter, genital staphylococcal infection and its relationship with infertility are discussed in detail.


2. Overview of staphylococcal infection

2.1. The staphylococci

Bacteria in the genus Staphylococcusare referred to Gram-positive spherical bacteria that widely affect man and other mammals. The bacteria are about 0.5–1.0 μm in diameter and grow in clusters, pairs, and occasionally in short chains. Staphylococci are divided into two groups based on their ability to clot blood plasma. The coagulase-positive staphylococci constitute the most pathogenic species Staphylococcus aureus. The coagulase-negative staphylococci (CNS) comprise over 30 other species, most of which are commensals of skin without causing infections. However, the incidence of infections of Staphylococcus epidermidisand other CNS has currently been rising. Among the known staphylococci, S. aureusis the most important human pathogen and causes a wide range of clinical infections [1]. It colonizes mainly the nasal passages, but also the other anatomical locales, such as skin, oral cavity, and gastrointestinal tract. Critically, S. aureushas been proved to be one of the most prevalent organisms in male and female genital tract, and its implication in the pathogenesis of reproductive diseases and infertility has attracted increasing attention [2]. In addition, the CNS stains such as S. epidermidisand Staphylococcus haemolyticusare also listed as the bacteria that can occupy and associated with male infertility.

2.2. The pathogenesis of Staphylococcus aureus

S. aureusis the leading cause of bacterial infections affecting an enormous population worldwide. By invading the bloodstream, lower respiratory tract, and skin and soft tissue, S. aureuscan potentially cause some of the most severe hospital-associated and community-acquired illnesses. S. aureusproduces a myriad of virulence factors that allow the organism to gain entry into tissues, attach to host cells, and secret exoproteins and toxins. The known virulence factors include lipoteichioic acid (LTA), toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxin A (SEA), and staphylococcal enterotoxin B. In addition, S. aureusexpresses a cohort of special factors that indirectly exert pathogenic effects through interfering with host defense mechanisms. This category involves capsular polysaccharide, protein A, and leukocidin. The classical Panton and Valentine (PV) leukocidin is considered as a contributing factor for necrotizing skin infections due to its leukotoxic activity [3]. Recently, a novel strategy was invented whereby S. aureussuccessfully escapes neutrophil-mediated defensive machinery and establishes its invasion and infection. In this case, S. aureussecretes the nuclease and adenosine synthase to convert neutrophil extracellular traps (NETs) to deoxyadenosine, which triggers the caspase-3-triggered death of immune cells [4].

2.3. The host defense against staphylococcal infection

Neutrophils represent the host’s first line of defense against invasion by S. aureusand a critical determinant in the outcome of staphylococcal infections. Following the uptake of bacteria, neutrophils typically undergo accelerated apoptosis and are cleared by macrophages through efferocytosis. This process results in eradication of the microbe and recovery of inflammation. The pathogen recognition pattern receptor, toll-like receptor (TLR2), is proved to be the dominant receptor for S. aureus. TLR2 on the surface of innate immune cells recognizes the components of the bacterial cell wall such as teichoic acid, LTA, and PGN-embedded lipopeptides [5]. TLR2 then dimerizes with either TLR1 or TLR6 and recruits the adaptor proteins, such as TIRAP and MyD88, and the serine/threonine kinases IRAK-1 and IRAK-4 to initiate the subsequent signaling. The signaling cascade ultimately leads to the activation of the transcription factor nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs), which promotes the production of proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-12p70 and chemokines such as (C-C motif) ligand (CCL)2, CCL3, and CCL4. Besides TLR2, C-type lecin receptors (CLRs) can also bind to surface sugars of S. aureusand enhance the phagocytic ability of antigen-presenting cells (APCs) [6]. The cytokines and chemokines released by the innate immune cells and/or the infected tissue cells have important roles in combating infection of S. aureus. They can recruit the innate immune cells to site of infection and activate the immune cells to phagocytose and kill the microbes. However, the extensive infiltration of inflammatory cells and the copious secretion of proinflammatory mediators may also cause tissue damage and immunopathology if the inflammation is unresolved.

When innate immune mechanisms are not sufficient to clear the bacterial infection, an adaptive immunity against S. aureus, such as T helper (Th)1 and Th17, and humoral antibody responses, might be required [7]. The production of IL-1 and IL-17A, upon activation of Th1 or Th17 cells, is presumably conductive to the abscess formation at site of infection. Abscessification is regarded as a hallmark of S. aureusinfections and is essential for the clearance of bacteria through phagocytosis and oxidative burst. On the other hand, Th1 response during S. aureusinfections is frequently associated with the activity of staphylococcal superantigens (SAgs). For example, TSS has been found to activate roughly 20% of T cells and trigger massive proliferation of T cells and production of cytokines [8]. A strong proinflammatory/Th1 response was also ascribed to the effect of SEA, which is another staphylococcal SAg.

2.4. Clinical manifestations of staphylococcal infection

Manifestations of staphylococcal infections usually depend on the type of infection, the site, the route, and the microbial dose. Common types of infections include skin infections (e.g. folliculitis, furuncles, impetigo, wound infections, and scalded skin syndrome), soft-tissue infections (e.g. pyomyositis, septic bursitis, and septic arthritis), toxic shock syndrome, purpura fulminans, endocarditis, osteomyelitis, pneumonia, food poisoning, and urinary tract infection [1, 9]. Despite associated with such a wide spectrum of clinical manifestations, S. aureusis still a commensal bacterium. Approximately 30% of the human population is colonized with this microbe [10]. However, with a growing number of health care–associated and antibiotic-resistant strain–driven infections, the pathogenic staphylococcal infection has significantly increased during the past two decades. In particular, the dramatic rising of antibiotic-resistant strains has become a serious threat to public health. The term MRSA refers to methicillin-resistant S. aureuswith the potential to resist all β-lactam antibiotics such as penicillins and cephalosporins. Resistance is usually conferred by the acquisition of a non-native gene encoding a penicillin-binding protein (PBP2a) that has significantly lower affinity for β-lactams [11]. In addition to MRSA, the vancomycin-intermediate/resistant S. aureus(VISA/VRSA) strain has also been reported in staphylococcal infection, particularly in some cases of enterococcal infection.


3. Epidemiology of genitourinary staphylococcal infection

Barring the role of a few bacteria such as Chlamydiawhose impact on fertility has been well established, the significance of other bacteria in infertility is controversial. An epidemiological research revealed that the prevalence of bacterial vaginosis (BV) as 70.34% among infertile women. Previously, the categories of organisms with the potential to cause bacterial infection in female reproductive system have involvedGardnerella vaginalis, Mobiluncussp., Bacteroidesp.,Prevotellasp., and Mycoplasmasp. [12]. In general, Gram-positive bacteria were significantly higher in number than the Gram-negative bacteria. Series of epidemiological studies have revealed that Staphylococcusis among the top bacterium detected from reproductive organs and is closely related with infertility. For example, Momoh et al. [13] reported a prevalence rate of 38.7% S. aureusfrom high vaginal swab and endocervical swabs and a prevalence of 75% from semen cultures of infertile couples. Another investigation identified S. aureusas the most prevalent vaginal pathogen (57.33%) among local infertile women, followed by Escherichia coli(25.33%) [14].

Parallel to the situation in females, abnormal presence of Staphylococcussp. has been increasingly evidenced in the genitourinary system of male patients with fertile problem. In a study of a total of 140 sperm samples collected from the University of Benin Teaching Hospital, S. aureus(28.3%) and S. saprohyticus(13.0%) were the most common pathogens found and have negative effects on sperm motility and morphology [15]. The commonest bacteria isolated from 160 men attending infertility clinics in South-eastern Nigeria were Proteussp., S. aureus, and E. coli, and most of the detected strains were resistant to antibiotics assessed[16]. Besides the S. aureus, other staphylococci are also commonly found in infertile male patients. S. epidermidiswas found to be one of the most common bacteria in 295 infertile males at the Hospital Juárez de México, and the bacteria profoundly affected the sperm motility, pH, morphology, and viscosity [17].

In healthy women of child-bearing age, the protective mucosa in the vagina is populated with microflora typically dominated by lactobacilli, and their dominance over pathogenic anaerobes is positively associated with vaginal health. Thanks to the biological antagonism provided by a healthy vaginal microbiota, opportunistic microorganisms are in very low numbers in normal vagina. It is proven that lactobacilli provide a constant acidic pH value and maintain the appropriate concentration of hydrogen peroxide in the genital environment. While under the condition of BV, the concentration of lactobacilli reduces but of some pathogenic bacteria, especially anaerobes or microaerophiles, increase [18]. BV represents the most common vaginal syndrome that affects fertile, premenopausal, and pregnant women, with an incidence rate ranging from 20% to 50% [19, 20]. BV is not caused by one specific pathogenic microorganism but rather by an imbalance of vaginal microbiota. Staphylococcussp., as a kind of amphimicrobian, has been established as one of the specific pathogenic bacteria related to BV. BV is frequently disregarded because the symptoms are often absent or insignificant. However, this vaginal disorder has already become the most common lower genital tract disorder among women of reproductive age and the most prevalent cause of vaginal discharge and malodour.

Genitourinary MRSA carriage and infection are not rare. A retrospective study was previously conducted on 57 pregnant women positive for MRSA over a 4.5-year period. The data showed that skin and soft tissue infection accounted for 96% of cases and recurrent infection occurred in 58% of the women [21]. Vaginal colonization with S. aureusand MRSA was further valuated by Chen et al., who reported that 507 S. aureusisolates (17.1%) were obtained from vaginal cultures of 2963 pregnant women, of which 14 (2.8%) were MRSA [22]. In addition, MRSA has become the predominant pathogen that causes the surgically managed infections in the genitourinary area.S. aureus,along withE. coli, Streptococci,andTrichomonas vaginalis, forms the abnormal vaginal flora that contributes to the onset of aerobic vaginitis. These pathogenic bacteria substantially alter the vaginal lactate concentration and increase the levels of inflammatory cytokines such as IL-6, IL-1β and leukemia inhibitory factor (LIF) in the vaginal fluid. Two methicillin-sensitive stains of S. aureus(MNPE and CDC587) have been documented to induce the expression of IL-8 in human vaginal epithelial cells [23]. Alterations in vaginal microbiology have been associated with many pathological conditions such as endometritis, miscarriage, premature labor, and infertility [24]. Moreover, the flora and cytokines imbalance has implicated in the pathogenesis of pelvic inflammatory disease (PID) and cervicitis and is also a risk factor for urinary tract infection and sexually transmitted disease (STD) [25].


4. Staphylococcal infection and male infertility

Urogenital tract infections in males are one of the significant etiological factors in infertility. The infection of bacteria such asStaphylococcussp. has been detected at the male reproductive tract. Staphylococcal infection in male reproductive organs and accessory glands may exert detrimental effect on sperm activity. Previous studies indicated that staphylococci not only affect the sperm activity but also impact the secretory capacity of the epididymis, seminal vesicles, and prostate [26]. In fact, staphylococci have been identified as one of the most common strains that can be detected in the male reproductive system. However, the percentages of males that get infected with staphylococci vary with the different isolation methods and procedures used in different studies. It has been demonstrated that S. aureusinfection significantly interferes with semen quality and activity. It deteriorates the volume of semen and the concentration of sperm as well as the motility, morphology, and vitality of sperm. Therefore, a causative relationship may exist between staphylococcal infection and male infertility. A previous study reported a 20.6% infection ofS. aureusin the semen samples from males with fertility problems. More importantly, S. aureusinfection was found to be closely related to poor semen quality and reduced sperm motility [27]. Also, an investigation by a Poland group associated S. aureusinfection with abnormal semen parameters or other surogenital tract infection [28].

Besides these prospective studies, several in vitrostudies also support the effect of Staphylococcuson sperm activity and its relation with infertility. It was revealed that infection of the normal human ejaculated spermatozoa with S. haemolyticusprofoundly impacted the architecture and integrity of the sperm plasma membrane. Bacterial infection serves as a contributing factor for severe injury of sperm membrane stability and mitochondrial activity with potential consequences of male fertility [29]. In addition, exposure of ejaculated spermatozoa to S. haemolyticuswas found to trigger a simultaneous decrease in the percentage of sperm with normal ΔΨm and an increase in the proportion of sperm with Annexin V staining, indicative of apoptotic cells. The data suggested a determinant role of staphylococcal infection in sperm fate [30]. Despite the above findings, the role for staphylococci in male infertility has remained somewhat controversial. A previous study showed that, although Staphylococcussp. was the most common bacteria isolated in 299 asymptomatic men undergoing fertility evaluation, the bacterial counts were not correlated with semen parameters [31].

In an effort to understand the mechanism whereby staphylococci modulate sperm activity, investigators currently identified some of the key molecules that have profound effect on sperm activity. Kaur and Prabhaet al.firstly identified sperm agglutinating factor (SAF). Based on the observation that S. aureuscan adhere to the sperm head as well as sperm tail and agglutinate mouse spermatozoa, the group finally isolated a protein with a molecular weight of approximately 57 kDa from S. aureusand implicated the protein in control of sperm motility and survival. Moreover, SAF potentially affects various sperm parameters such as Mg2+-dependent ATPase activity, acrosome status, and apoptosis. In support of this, a profound morphological alteration occurs in the spermatozoa upon binding with SAF, as detected with scanning electron microscopy. Also, SAF has a spermicidal effect at high concentrations and may have the potential to function as active ingredient of a vaginal contraceptive. Further studies indicate that the interaction of SAF with spermatozoa is receptor mediated, and the receptor has been isolated and purified from human spermatozoa. This sperm surface receptor component showed homology to glutamate decarboxylase and major histocompatibility complex (MHC) class I molecule [32]. Intriguingly, the receptor was shown to be able to counteract the detrimental effects of SAF on sperm parameters and alleviate SAF-induced infertility in mice [33]. In addition, Prabhaet al.isolated the SAF from an E. colistrain. This kind of SAF also leads to sperm agglutination, the compromised Mg2+-dependent ATPase activity, and spermatozoa apoptosis.

In 2009, another protein with sperm regulatory effect, named sperm immobilization factor (SIF), was identified fromS. aureus. SIF is a protein with the molecular weight of approximately 20 kDa. Similar to SAF, SIF causes multiple defects in the head, midpiece, neck, and tail region of human spermatozoa [34]. It can completely inhibit Mg2+ ATPase activity of spermatozoa at the concentration of 100 μg/ml and reduce calcium ionophore–induced acrosome reaction. The interaction between SIF and spermatozoa is also ligand-receptor dependent. The analysis by matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) showed that the receptor shares sequence similarity with MHC class II antigen. Interestingly, SIF has been found to impede motile bacteria, in addition to sperm, such asE. coli, Pseudomonas aeruginosa, and Proteus mirabilis. The molecular mimicry of SIF receptor has been confirmed between spermatozoa and bacteria [35].

In addition to the effector molecules mentioned above, some novel mechanisms responsible for the staphylococcal regulation of sperm have now been discovered. A recent study on the semen of 589 infertile males indicated that other virulence genes in S. aureus, such as hlg (33.3%), scn (23.3%), cna (20%), hlb (20%), and clfA (18.3%), were possibly responsible for spermatozoal immobilization [36]. Berktas et al. raised another point of view that, rather than the direct interaction between bacteria and sperm, the alteration in genital microenvironment or ver-consumption of energy by high dose of bacterium led to the loss of sperm motility [37].


5. Staphylococcal infection and female infertility

Bacterial infection in female reproductive system, such as staphylococcal infection, can profoundly affect all the phases of a woman’s life in relation to the period of pre-pregnancy, fertilization, pregnancy, and reproduction. It has been demonstrated that BV is the most common lower genital tract disorder among women of reproductive age. In particular, staphylococcal infection is presumed to be a contributing factor for the adverse pregnancy outcomes and female infertility. Staphylococcal infection causes malodorous vaginal discharge and is causally associated with sexually transmitted infections. Also, it has been implicated in the development of endometritis (endometriosis), another crucial factor to female infertility.

5.1. Inflammatory response and hypothalamic endocrine

An immune/inflammatory challenge is considered as an important factor that impinges the reproduction process in animals and humans [38]. It can affect reproduction at the level of the hypothalamus, pituitary gland, or gonads. Nonetheless, the major impact is thought to occur within the brain or the pituitary gland [39]. Bacterial endotoxins can trigger the release of cytokines and other immune mediators in the hypothalamus, where the luteinizing hormone (LH)-releasing hormone and gonadotropin-releasing hormone (GnRH) neurons are located [40]. Numerous in vitroand in vivostudies showed that the immune stress and the subsequent action of proinflammatory cytokines have a profound impact on the secretory activity of GnRH and LH neurons in the hypothalamus [41]. These interconnections between the immune and the neuroendocrine systems are suggested to be based on the mutual sharing of receptors and mediators.

As described above, staphylococcal infection either in peripheral or directly in vagina can arouse strong immune/inflammatory reaction systematically or locally. The released cytokines and chemokines then act on the pituitary gland and reproductive organs, which may finally lead to menoxenia, irregular ovulation, and infertility. Evidences have shown that staphylococcal infection generates a large quantity of cytokines in female reproductive system. These mediators have an important role in the control of reproductive neuroendocrine, ovarian physiology, fetal implantation and development, and placenta function. Previous study revealed a correlation between BV, elevated IL-1β and IL-8, and idiopathic infertility, suggesting that abnormal vaginal flora and the vaginal inflammatory response may be responsible for the idiopathic infertility in women undergoing in vitrofertilization [42].

5.2. Premature ovarian failure

Female mammals are born with a finite number of oocytes that gradually decreases during prepubertal development and adult life [43]. Each oocyte is encircled by somatic granulosa cells (GCs) to form the basic functioning unit of the ovary—the follicle. The size of the oocytes at birth and the rate of endowment depletion dominate the ovarian functional lifespan. On the other hand, programmed cell death (apoptosis) has been considered one of the most prevalent mechanisms that contribute to the age-related exhaustion of oocytes. Therefore, a precise balance has to be achieved between prosurvival and proapoptotic molecules to maintain the final destiny of the follicle [44, 45].

It is well recognized that immune/inflammatory response participates in many aspects of reproductive physiology, such as ovulation, menstruation, and implantation. Recent studies suggest that the inflammatory stress caused by staphylococcal infection may also affect ovarian reserve and cyclicity in women. Proinflammatory reaction, such as its correspondent neurotransmitter secretion, inflammatory gene transcription, and signaling pathway activation, was thought to play essential roles in the process. Moreover, the production of neurotransmitter, such as sphingolipid ceramide, further acts as a second messenger to promote age-related apoptosis of oocytes. Evidence showed that lower ceramide levels observed in acid sphingomyelinase-deficient mice resulted in a larger postnatal pool of oocytes compared with their wild-type counterparts. Conversely, Bax-null female mice exhibited to extend the ovarian lifespan [46]. These data may provide novel perspectives on the regulation of oocyte dynamics by bacterial infection and link the critical biological processes such as infection, inflammation, cell survival, and female fertility.

5.3. Bacterial vaginosis and endometritis

BV is a polymicrobial syndrome mainly due to an imbalance of vaginal microbiota. Colonization and proliferation of staphylococci is supposed to be one of the reasons for the increase in pathogenic bacteria, anaerobic bacteria, or microaerophiles. During the pathogenesis of BV, the overgrowth of anaerobes promotes the production of noxious substances, such as polyamines and other compounds. These metabolic products may further trigger the release of proinflammatory cytokines IL-1β and IL-8 and thus cause tissue damage and physiological imbalance [47]. BV can directly affect congenital formation and female fertility as an ascending dissemination of the related bacteria species proved to cause tubal factor infertility.

Another complication accompanied by vaginal staphylococcal infection is chronic endometritis (CE), a local inflammatory disease characterized by unusual plasmacytic infiltration in the endometrial stromal areas [48]. CE frequently happens in the later stage of the infection or under repeated infection. It tends to be neglected in gynecologic practice because of its less apparent symptom and the requirement of time-consuming histopathologic examinations. In most cases, the diagnosis is made based on gynecological indications, such as abnormal uterine bleeding (AUB) and infertility [49]. In a study on 64 CE patients and 28 healthy women, the biochemical analysis revealed that IL-6, IL-1β, and TNF-α levels were markedly higher in menstrual effluents of women with CE when compared with control subjects [50]. It is suggested that the infection and inflammation alter the endometrial cytokine profiles, which may further impair endometrial function and lead to menstrual abnormalities and reduced embryo receptivity [51]. Moreover, the proteomic analysis identified the key signaling pathways involved in inflammation and oxidative stress are closely related with carcinogenetic processes. These studies associate the onset of CE with female infertility, obstetric and neonatal abnormity, and complications. The altered endometrial gene expression may explain the impaired endometrial receptivity and endometrial hyperplastic lesions observed in women affected by CE [52].

5.4. Abnormal fetal implantation

In rodents and humans, implantation is the first coordinated encounter between mother and baby. The abnormal implantation and placentation may lead to various dysfunctions throughout the pregnancy. Pre-eclampsia (PE) is a pregnancy-induced disorder characterized by hypertension and proteinuria. It is estimated to affect about 8% of pregnancies and is thought to be unique to humans [53]. The etiology of PE still remains poorly understood, but abnormal placentation is proved to be a major reason for this disease. In addition, local infection and immune responses are critically involved in the process of implantation [54]. Increased placental secretion of proinflammatory cytokines as well as the angiogenic regulators has been implicated in the widespread maternal endothelial dysfunction and the development of PE. It has been shown that cytokines produced within the uterine microenvironment can alter trophoblast action [55], impair implantation, and placenta vascularization, which may account for the recurrent miscarriage in women [56]. Elevated circulating IL-15 levels, proportional to severity of diseases, have been detected in the serum of PE mothers when compared with healthy controls [57]. Also, IL-11 is also proved to be a contributing factor for the impaired trophoblast invasion, spiral artery remodeling, and altered placental labyrinth morphology. These functional abnormities further lead to the development of PE-like features, such as elevated systolic blood pressure (SBP), proteinuria, and kidney glomerular pathology. Another proinflammatory cytokine, interferon (IFN)-γ, was also elevated in plasma, circulating leukocytes, and decidua of patients with PE [58]. Besides this, decidual natural killer (dNK) cells, the predominant immune cell, coincide with the decidualization at the maternal-fetal interface in human and mice. All of these studies point to a critical role of immune/inflammatory response during the implanting and placental development. More importantly, vaginal Staphylococcusinfection, an infectious agent frequently observed in the uterus, may participate in the development of implantation disorder presumably by the induction of local immune reaction.


6. Therapy

Antibiotic strategy is considered the most potential therapeutic methods against staphylococcal infection and the resultant infertility. However, the emergence of antibiotic resistance has dramatically increased in the past two decades and becomes a serious threat to the worldwide public health. According to the National Healthcare Safety Network (NHSN) and Centers for Disease Control and Prevention, S. aureusand Enterococcusare the two most commonly reported pathogens, accounting for 15.6% and 13.9% of health care–associated infections, respectively. In particular, S. aureusis notorious for its ability to acquire the resistance to any antibiotic during the treatment of infection-associated infertility.

6.1. Methicillin

The introduction of penicillin in the early 1940s significantly reduced fatal invasive staphylococcal infection. However, the resistant strains, mostly S. aureusstrains, emerged rapidly. These strains possess a plasmid-encoding enzyme, penicillinase, which can irreversibly hydrolyze the β-lactam, thus acquiring the drug resistance. Methicillin is a narrow-spectrum β-lactam antibiotic of the penicillin class. It can effectively block the synthesis of bacterial cell walls by inhibiting the peptidic cross-linkage between the linear peptidoglycan polymer chains. Therefore, the antibiotic destroys the integrity of the cell wall and selectively kills Gram-positive bacteria. Compared with penicillin, methicillin harbors an orthodimethoxyphenyl group attached to the side chain of the β-lactam, which, in turn, forms a steric effect to prevent penicillinase from hydrolyzing the β-lactam. Even though, the first strain of MRSA, with an altered PBP2a to reduced affinity for the β-lactam, was reported two years later [59]. Now, MRSA refers to any strain of S. aureusthat has developed resistance to β-lactam antibiotics such as the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. Resistance is generally conferred by the acquisition of the mecA gene, which encodes a PBP2a. Due to the significantly decreased affinity for β-lactams, MRSA strains restore the ability of cell wall biosynthesis to continue even in the presence of typically inhibitory concentrations of antibiotic [11].

6.2. Vancomycin

Vancomycin belongs to the glycopeptide antibiotic class and is effective in treatment of serious infections caused by Staphylococcus. It is one of the main resources for combating infections caused by MRSA but is not recommended to treat the disease caused by methicillin-sensitive S. aureus(MSSA). Vancomycin is a complex compound consisting of a branched tricyclic glycosylated peptide and is a rare example of a halo-organic natural compound containing two covalently bonded chlorine atoms. The bactericidal activity of vancomycin is associated with its ability to bind at the D-Ala-D-Ala dipeptide terminus of the nascent peptidoglycan in Gram-positive bacteria and thereby to inhibit the peptidoglycan synthesis [60]. Common side effects associated this antibiotic involve pain in the area of injection and allergic reactions, and problems with hearing, low blood pressure, or bone marrow suppression occasionally occur. The strain with the reduced susceptibility to vancomycin (VISA) was first described in 1996, and the alteration of the D-Ala-D-Ala dipeptide was supposed to be the main reason underlying this resistance.

6.3. Linezolid

Linezolid has been used for treatment of serious infections caused by Gram-positive bacteria that are resistant to other antibiotics such as MRSA. Its spectrum of activity is similar to that of vancomycin, a well-established antibiotic for MRSA infections. Either linezolid or vancomycin has been recommended by the US guidelines as the first-line treatment for hospital-acquired (nosocomial) MRSA pneumonia [61]. Mechanistically, linezolid binds to the 50s subunit of the bacterial ribosome through interaction with the central loop of the 23S rRNA and thus impedes the growth of bacteria by disrupting their production of proteins. Point mutation of 23S rRNA is the most common mechanism of linezolid resistance [62]. The common side effects of linezolid include diarrhea, headache, nausea, vomiting, rash, constipation, altered taste perception, and discoloration of the tongue, although they happen relatively rarely.

6.4. Daptomycin

Daptomycin is the first cyclic lipopeptide approved for clinical use in 2003. It is a calcium-dependent antibiotic comprising a lipid molecule conjugated with anionic peptide. Daptomycin interacts with the cytoplasmic membrane in a calcium-dependent, leading to the cell membrane depolarization, ion loss, and cell death [63]. Many antibiotic-resistant strains, such as MRSA and VRSA, were found to be effectively inhibited by daptomycin. Till 2008, the first case of daptomycin resistance was reported, and the underlying mechanism is currently still not very clear [64]. However, the mutation of the mprF gene, which encodes lysyl-phosphatidyl glycerol (LPG) synthetase, might be related to the occurrence of resistant strains. LPG can catalyze the coupling of lysine to PG and transfer the lysyl-PG to the outer leaflet of the membrane. In this way, LPG increases the positive charge and thus reduces the binding of Ca2+-bound daptomycin to bacterial membranes [65].

Besides the routinely used antibiotics mentioned above, numerous new antibiotics are developed to serve as the alternatives in treating staphylococcal infection and the associated infertility. For example, teicoplanin or quinupristin/dalfopristin has been widely used with daptomycin to treat Gram-positive bacterial infection. Some of the potential antibiotics, such as oritavancin and iclaprim, are currently in the early stages of clinical development, and other promising candidates, such as ceftobiprole, dalbavancin, and telavancin, are still being developed [66].


  1. 1. Lowy FD.Staphylococcus aureusinfections. N Engl J Med. 1998;339:520–532.
  2. 2. Guinan ME, Dan BB, Guidotti RJ, Reingold AL, Schmid GP, Bettoli EJ, Lossick JG, Shands KN, Kramer MA, Hargrett NT, Anderson RL, Broome CV. Vaginal colonization withStaphylococcus aureusin healthy women: a review of four studies. Ann Intern Med. 1982;96:944–947. DOI:10.7326/0003-4819-96-6-944
  3. 3. Pauli NT, Kim HK, Falugi F, Huang M, Dulac J, Henry Dunand C, Zheng NY, Kaur K, Andrews SF, Huang Y, DeDent A, Frank KM, Charnot-Katsikas A, Schneewind O, Wilson PC.Staphylococcus aureusinfection induces protein A-mediated immune evasion in humans. J Exp Med. 2014;211:2331–2339. DOI:10.1084/jem.20141404
  4. 4. Thammavongsa V, Missiakas DM, Schneewind O.Staphylococcus aureusdegrades neutrophil extracellular traps to promote immune cell death. Science 2013;342:863–866. DOI:10.1126/science.1242255
  5. 5. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805–820. DOI:10.1016/j.cell.2010.01.022
  6. 6. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002;2:77–84. DOI:10.1038/nri723
  7. 7. Miller LS, Cho JS. Immunity againstStaphylococcus aureuscutaneous infections. Nat Rev Immunol. 2011;11:505–518. DOI:10.1038/nri3010
  8. 8. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77–104.
  9. 9. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661. DOI:10.1128/CMR.00134-14
  10. 10. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage inStaphylococcus aureusinfections. Lancet Infect Dis. 2005;5:751–762.
  11. 11. Peacock SJ, Paterson GK. Mechanisms of methicillin resistance inStaphylococcus aureus. Annu Rev Biochem. 2015;84:577–601. DOI:10.1146/annurev-biochem-060614-034516
  12. 12. Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993;169:455–459.
  13. 13. Momoh ARM, Orhue PO, Okolo PO, Odaro D, Momoh AA. The antibiogram types of auto-agglutinatingStaphylococcus aureusstrains isolated from the semen samples of males with infertility problems in Edo state, Nigeria. E3 J Med Res. 2012;1:17–24.
  14. 14. Ghiasi M, Fazaeli H, Kalhor N, Sheykh-Hasan M, Tabatabaei-Qomi R. Assessing the prevalence of bacterial vaginosis among infertile women of Qom city. Iran J Microbiol. 2014;6:404–408.
  15. 15. Isaiah IN, Nche BT, Nwagu IG, Nnanna II. Current studies on bacterospermia the leading cause of male infertility: a protégé and potential threat towards mans extinction. N Am J Med Sci. 2011;3:562–564. DOI:10.4297/najms.2011.3559
  16. 16. Uneke CJ, Ugwuoru CD. Antibiotic susceptibility of urogenital microbial profile of infertile men in South-eastern Nigeria. Andrologia 2010;42:268–273. DOI:10.1111/j.1439-0272.2009.00988.x
  17. 17. Huerta M, Cervera Aguilar R, Hernández I, Ayala AR. Frequency and etiology of seminal infections in the study of infertile couples. Ginecol Obstet Mex. 2002;70:90–94.
  18. 18. Mastromarino P, Vitali B, Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013;36:229–238.
  19. 19. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstet Gynecol. 2007;109:114–120. DOI:10.1016/S0920-5861(96)00164-2
  20. 20. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE. The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive. Sex Transm Dis. 2007;34:864–869.
  21. 21. Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S, Wendel GD Jr. Clinical presentation of community-acquired methicillin-resistantStaphylococcus aureusin pregnancy. Obstet Gynecol. 2005;106:461–465.
  22. 22. Chen KT, Huard RC, Della-Latta P, Saiman L. Prevalence of methicillin-sensitive and methicillin-resistantStaphylococcus aureusin pregnant women. Obstet Gynecol. 2006;108:482–487. DOI:10.1097/01.AOG.0000227964.22439.e3
  23. 23. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002;109:34–43. DOI:10.1111/j.1471-0528.2002.00432.x
  24. 24. Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis. 2002;35:S152–S172.
  25. 25. Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Gaughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol. 2000;95:710–712.
  26. 26. Marconi M, Pilatz A, Wagenlehner F, Diemer T, Weidner W. Impact of infection on the secretory capacity of the male accessory glands. Int Braz J Urol. 2009;35:299–308.
  27. 27. Onemu SO, Ibeh IN. Studies on the significance of positive bacterial semen cultures in male fertility in Nigeria. Int J Fertil Womens Med. 2001;46:210–214.
  28. 28. Filipiak E, Marchlewska K, Oszukowska E, Walczak-Jedrzejowska R, Swierczynska-Cieplucha A, Kula K, Slowikowska-Hilczer J. Presence of aerobic micro-organisms and their influence on basic semen parameters in infertile men. Andrologia 2015;47:826–831. DOI:10.1111/and.12338
  29. 29. Fraczek M, Piasecka M, Gaczarzewicz D, Szumala-Kakol A, Kazienko A, Lenart S, Laszczynska M, Kurpisz M. Membrane stability and mitochondrial activity of human-ejaculated spermatozoa during in vitro experimental infection withEscherichia coli,Staphylococcus haemolyticusandBacteroides ureolyticus. Andrologia 2012;44:315–329. DOI:10.1111/j.1439-0272.2012.01283.x
  30. 30. Fraczek M, Hryhorowicz M, Gaczarzewicz D, Szumala-Kakol A, Kolanowski TJ, Beutin L, Kurpisz M. Can apoptosis and necrosis coexist in ejaculated human spermatozoa during in vitro semen bacterial infection? J Assist Reprod Genet 2015;32:771–779. DOI:10.1007/s10815-015-0462-x
  31. 31. Rodin DM, Larone D, Goldstein M. Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation. Fertil Steril 2003;79(Suppl. 3):1555–1558.
  32. 32. Kaur K, Prabha V. Impairment by sperm agglutinating factor isolated fromEscherichia coli: receptor specific interactions. Biomed Res Int. 2013;2013:548497. DOI:10.1155/2013/548497
  33. 33. Kaur S, Prabha V. Receptor mediated amelioration of the detrimental effects of sperm agglutinating factor on sperm parameters. Andrology 2013;1:624–631. DOI:10.1111/j.2047-2927.2013.00088.x
  34. 34. Prabha V, Gupta T, Kaur S, Kaur N, Kala S, Singh A. Isolation of a spermatozoal immobilization factor fromStaphylococcus aureusfiltrates. Can J Microbiol. 2009;55:874–878. DOI:10.1139/w09-032
  35. 35. Prabha V, Chaudhary N, Kaur S. Molecular mimicry between spermatozoa and bacteria. J Urol. 2011;186:2442–2447. DOI:10.1016/j.juro.2011.07.084
  36. 36. Li B, Yang X, Ye JZ, Chen HL, Hou YB, Du J, Zhou TL. Spermatozoal immobilization ability and virulence genes ofStaphylococcus aureusisolated from the semen of infertile men. Zhonghua Nan Ke Xue. 2015;21:881–886.
  37. 37. Berktas M, Aydin S, Yilmaz Y, Cecen K, Bozkurt H. Sperm motility changes after coincubation with various uropathogenic microorganisms: an in vitro experimental study. Int Urol Nephrol. 2008;40:383–389. DOI:10.1007/s11255-007-9289-4
  38. 38. Herman AP, Krawczynska A, Bochenek J, Dobek E, Herman A, Tomaszewska-Zaremba D. LPS-induced inflammation potentiates the IL-1beta-mediated reduction of LH secretion from the anterior pituitary explants. Clin Dev Immunol. 2013;2013:926937. DOI:10.1155/2013/926937
  39. 39. Herman AP, Tomaszewska-Zaremba D. Effect of endotoxin on the expression of GnRH and GnRHR genes in the hypothalamus and anterior pituitary gland of anestrous ewes. Anim Reprod Sci. 2010;120:105–111. DOI:10.1016/j.anireprosci.2010.03.011
  40. 40. Igaz P, Salvi R, Rey JP, Glauser M, Pralong FP, Gaillard RC. Effects of cytokines on gonadotropin-releasing hormone (GnRH) gene expression in primary hypothalamic neurons and in GnRH neurons immortalized conditionally. Endocrinology 2006;147:1037–1043.
  41. 41. Refojo D, Arias P, Moguilevsky JA, Feleder C. Effect of bacterial endotoxin on in vivo pulsatile gonadotropin secretion in adult male rats. Neuroendocrinology 1998;67:275–281.
  42. 42. Spandorfer SD, Neuer A, Giraldo PC, Rosenwaks Z, Witkin SS. Relationship of abnormal vaginal flora, proinflammatory cytokines and idiopathic infertility in women undergoing IVF. J Reprod Med. 2001;46:806–810.
  43. 43. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465–493. DOI:10.1210/er.2009-0006
  44. 44. Tilly JL. Apoptosis and ovarian function. Rev Reprod. 1996;1:162–172.
  45. 45. Hussein MR. Apoptosis in the ovary: molecular mechanisms. Hum Reprod. 2005;11:162–177.
  46. 46. Uri-Belapolsky S, Shaish A, Eliyahu E, Grossman H, Levi M, Chuderland D, Ninio-Many L, Hasky N, Shashar D, Almog T, Kandel-Kfir M, Harats D, Shalgi R, Kamari Y. Interleukin-1 deficiency prolongs ovarian lifespan in mice. Proc Natl Acad Sci USA. 2014;111:12492–12497. DOI:10.1073/pnas.1323955111
  47. 47. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004;190:1509–1519.
  48. 48. Kitaya K, Matsubayashi H, Yamaguchi K, Nishiyama R, Takaya Y, Ishikawa T, Yasuo T, Yamada H. Chronic endometritis: potential cause of infertility and obstetric and neonatal complications. Am J Reprod Immunol. 2016;75:13–22. DOI:10.1111/aji.12438
  49. 49. Gilmore H, Fleischhacker D, Hecht JL. Diagnosis of chronic endometritis in biopsies with stromal breakdown. Hum Pathol. 2007;38:581–584. DOI:10.1016/j.humpath.2006.09.002
  50. 50. Tortorella C, Piazzolla G, Matteo M, Pinto V, Tinelli R, Sabba C, Fanelli M, Cicinelli E. Interleukin-6, interleukin-1beta, and tumor necrosis factor alpha in menstrual effluents as biomarkers of chronic endometritis. Proc Natl Acad Sci USA. 2014;112:15928–15933. DOI:10.1073/pnas.1515076112
  51. 51. Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol. 2011;335:42–51. DOI:10.1016/j.mce.2010.08.006
  52. 52. Di Pietro C, Cicinelli E, Guglielmino MR, Ragusa M, Farina M, Palumbo MA, Cianci A. Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol. 2013;69:509–517. DOI:10.1111/aji.12076
  53. 53. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
  54. 54. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387–411. DOI:10.1146/annurev-immunol-032712-100003
  55. 55. Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod. 2005;11:613–630. DOI:10.1093/humupd/dmi023
  56. 56. Toth B, Haufe T, Scholz C, Kuhn C, Friese K, Karamouti M, Makrigiannakis A, Jeschke U. Placental interleukin-15 expression in recurrent miscarriage. Am J Reprod Immunol. 2010;64:402–410. DOI:10.1111/j.1600-0897.2010.00879.x
  57. 57. Sones JL, Lob HE, Isroff CE, Davisson RL. Role of decidual natural killer cells, interleukin-15, and interferon-gamma in placental development and preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2014;307:R490–R492. DOI:10.1152/ajpregu.00176.2014
  58. 58. Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J, Croy BA. Interferon gamma in successful pregnancies. Biol Reprod. 2009;80:848–859. DOI:10.1095/biolreprod.108.073353
  59. 59. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistantStaphylococcus aureusUSA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42:647–656.
  60. 60. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42(Suppl. 1):S5–S12.
  61. 61. American Thoracic Society & Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health care-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416. DOI:10.1164/rccm.200405-644ST
  62. 62. Mendes RE, Deshpande LM, Jones RN. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist. 2014;17:1–12. DOI:10.1016/j.drup.2014.04.002
  63. 63. Patel D, Husain M, Vidaillac C, Steed ME, Rybak MJ, Seo SM, Kaatz GW. Mechanisms of in-vitro-selected daptomycin-non-susceptibility inStaphylococcus aureus. Int J Antimicrob Agents. 2011;38:442–446. DOI:10.1016/j.ijantimicag.2011.06.010
  64. 64. Hobbs JK, Miller K, O’Neill AJ, Chopra I. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J Antimicrob Chemother. 2008;62:1003–1008. DOI:10.1093/jac/dkn321
  65. 65. Jones T, Yeaman MR, Sakoulas G, Yang SJ, Proctor RA, Sahl HG, Schrenzel J, Xiong YQ, Bayer AS. Failures in clinical treatment ofStaphylococcus aureusinfection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother. 2008;52:269–278.
  66. 66. Vuong C, Yeh AJ, Cheung GY, Otto M. Investigational drugs to treat methicillin-resistantStaphylococcus aureus. Expert Opin Investig Drugs. 2016;25:73–93. DOI:10.1517/13543784.2016.1109077

Written By

Liyun Shi, Huanhuan Wang and Zhe Lu

Submitted: October 5th, 2015 Reviewed: February 23rd, 2016 Published: June 29th, 2016